Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
New Managers April 2014

NEW LAUNCHES: Latest and announced maiden fund launches

We recently heard of those ex-hedge funders striking out on their own:

  • Magnetar Capital LLC's Min Htoo and Jordan Teramo plan to start an event driven hedge fund as investor demand for the strategy helps push industry assets to a record, reports BusinessWeek. Htoo, a partner at the $10bn investment firm, will be CEO of Anandar Capital Management LP, which aims to commence operations in May.
  • Former Soros managers Kenneth Lee and Michael Yoshinowill start a Hong Kong-based hedge fund in the third quarter of 2014 with at least $150 million in initial capital including seed capital from HS Group, making it one of the biggest start-ups in the region this year, reports Reuters. The long/short equity hedge fund firm, Pleiad Investment Advisors, will focus on investments in China and Japan.
  • The original architects of PIMCO's Unconstrained Bond Fund have teamed up for a new unconstrained fund utilizing their existing experience and best new ideas. The Anfield Universal Fixed Income Fund (AFLIX), takes a "go anywhere" approach to managing fixed income, seeking to be more opportunistically positioned compared to traditional, benchmarked core plus funds. "As interest rates begin to normalize and inflation follows suit, fixed income investors need a flexible-core strategy that isn't wed to a benchmark and has few investment restrictions in the attempt to achieve risk-managed returns regardless of interest rate movements," said David Young, Founder and CEO, in an interview with Opalesque.
  • ......................

    To view our full article please login

    This article was published in Opalesque's New Managers a top-down monthly analysis, news and research publication on the global emerging manager space.
    New Managers
    New Managers
    New Managers

  • Today's Exclusives Today's Other Voices More Exclusives
    Previous Opalesque Exclusives                                  
    More Other Voices
    Previous Other Voices                                               
    Access Alternative Market Briefing


    • Top Forwarded
    • Top Tracked
    • Top Searched
    1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

      Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

    2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

      Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

    3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

      Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

    4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

      From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

    5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

      From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for